chr17-65193569-C-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_003835.4(RGS9):​c.773C>T​(p.Ser258Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00515 in 1,613,216 control chromosomes in the GnomAD database, including 138 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.0050 ( 14 hom., cov: 32)
Exomes 𝑓: 0.0052 ( 124 hom. )

Consequence

RGS9
NM_003835.4 missense

Scores

18

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: -0.773

Publications

12 publications found
Variant links:
Genes affected
RGS9 (HGNC:10004): (regulator of G protein signaling 9) This gene encodes a member of the RGS family of GTPase activating proteins that function in various signaling pathways by accelerating the deactivation of G proteins. This protein is anchored to photoreceptor membranes in retinal cells and deactivates G proteins in the rod and cone phototransduction cascades. Mutations in this gene result in bradyopsia. Multiple transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, Sep 2009]
RGS9 Gene-Disease associations (from GenCC):
  • prolonged electroretinal response suppression 1
    Inheritance: AR Classification: DEFINITIVE Submitted by: G2P
  • bradyopsia
    Inheritance: AR Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Ambry Genetics, Orphanet, ClinGen, Labcorp Genetics (formerly Invitae), PanelApp Australia

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0018083751).
BP6
Variant 17-65193569-C-T is Benign according to our data. Variant chr17-65193569-C-T is described in ClinVar as Benign. ClinVar VariationId is 167593.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population eas. GnomAd4 allele frequency = 0.00505 (769/152292) while in subpopulation EAS AF = 0.0338 (175/5178). AF 95% confidence interval is 0.0297. There are 14 homozygotes in GnomAd4. There are 446 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 14 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
RGS9NM_003835.4 linkc.773C>T p.Ser258Leu missense_variant Exon 12 of 19 ENST00000262406.10 NP_003826.2 O75916-1A8K1G1
RGS9NM_001081955.3 linkc.764C>T p.Ser255Leu missense_variant Exon 12 of 19 NP_001075424.1 O75916-5
RGS9NM_001165933.2 linkc.764C>T p.Ser255Leu missense_variant Exon 12 of 17 NP_001159405.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
RGS9ENST00000262406.10 linkc.773C>T p.Ser258Leu missense_variant Exon 12 of 19 1 NM_003835.4 ENSP00000262406.9 O75916-1

Frequencies

GnomAD3 genomes
AF:
0.00497
AC:
757
AN:
152174
Hom.:
12
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000314
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00687
Gnomad ASJ
AF:
0.00837
Gnomad EAS
AF:
0.0337
Gnomad SAS
AF:
0.0331
Gnomad FIN
AF:
0.0106
Gnomad MID
AF:
0.0285
Gnomad NFE
AF:
0.00213
Gnomad OTH
AF:
0.00430
GnomAD2 exomes
AF:
0.00928
AC:
2316
AN:
249562
AF XY:
0.0105
show subpopulations
Gnomad AFR exome
AF:
0.000323
Gnomad AMR exome
AF:
0.00437
Gnomad ASJ exome
AF:
0.00764
Gnomad EAS exome
AF:
0.0270
Gnomad FIN exome
AF:
0.00955
Gnomad NFE exome
AF:
0.00241
Gnomad OTH exome
AF:
0.0112
GnomAD4 exome
AF:
0.00516
AC:
7543
AN:
1460924
Hom.:
124
Cov.:
30
AF XY:
0.00601
AC XY:
4366
AN XY:
726842
show subpopulations
African (AFR)
AF:
0.000448
AC:
15
AN:
33468
American (AMR)
AF:
0.00411
AC:
184
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
0.00777
AC:
203
AN:
26122
East Asian (EAS)
AF:
0.0402
AC:
1597
AN:
39684
South Asian (SAS)
AF:
0.0342
AC:
2948
AN:
86218
European-Finnish (FIN)
AF:
0.00917
AC:
490
AN:
53420
Middle Eastern (MID)
AF:
0.0208
AC:
120
AN:
5764
European-Non Finnish (NFE)
AF:
0.00138
AC:
1535
AN:
1111166
Other (OTH)
AF:
0.00747
AC:
451
AN:
60360
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.462
Heterozygous variant carriers
0
379
758
1138
1517
1896
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
102
204
306
408
510
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00505
AC:
769
AN:
152292
Hom.:
14
Cov.:
32
AF XY:
0.00599
AC XY:
446
AN XY:
74466
show subpopulations
African (AFR)
AF:
0.000313
AC:
13
AN:
41558
American (AMR)
AF:
0.00686
AC:
105
AN:
15300
Ashkenazi Jewish (ASJ)
AF:
0.00837
AC:
29
AN:
3466
East Asian (EAS)
AF:
0.0338
AC:
175
AN:
5178
South Asian (SAS)
AF:
0.0330
AC:
159
AN:
4824
European-Finnish (FIN)
AF:
0.0106
AC:
112
AN:
10610
Middle Eastern (MID)
AF:
0.0306
AC:
9
AN:
294
European-Non Finnish (NFE)
AF:
0.00213
AC:
145
AN:
68036
Other (OTH)
AF:
0.0104
AC:
22
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
38
75
113
150
188
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00402
Hom.:
28
Bravo
AF:
0.00369
TwinsUK
AF:
0.00135
AC:
5
ALSPAC
AF:
0.000778
AC:
3
ESP6500AA
AF:
0.000739
AC:
3
ESP6500EA
AF:
0.00155
AC:
13
ExAC
AF:
0.00951
AC:
1150
Asia WGS
AF:
0.0400
AC:
140
AN:
3478
EpiCase
AF:
0.00273
EpiControl
AF:
0.00338

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Jan 23, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
Apr 12, 2017
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.049
BayesDel_addAF
Benign
-0.67
T
BayesDel_noAF
Benign
-0.70
CADD
Benign
4.1
DANN
Benign
0.80
DEOGEN2
Benign
0.022
T;.;.;T
Eigen
Benign
-1.3
Eigen_PC
Benign
-1.2
FATHMM_MKL
Benign
0.017
N
LIST_S2
Benign
0.74
T;T;T;T
MetaRNN
Benign
0.0018
T;T;T;T
MetaSVM
Benign
-0.99
T
MutationAssessor
Benign
-0.24
.;.;.;N
PhyloP100
-0.77
PrimateAI
Benign
0.42
T
PROVEAN
Benign
-1.9
.;.;N;N
REVEL
Benign
0.0080
Sift
Benign
0.53
.;.;T;T
Sift4G
Benign
0.36
.;T;T;T
Polyphen
0.0040, 0.0050
.;.;B;B
Vest4
0.14, 0.13, 0.14
MVP
0.30
MPC
0.16
ClinPred
0.0023
T
GERP RS
-2.4
Varity_R
0.067
gMVP
0.41
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs12452285; hg19: chr17-63189687; COSMIC: COSV52225553; API